The lentivirus vectors LV–NC–shRNA, LV-CCDC115-shRNA and LV-CCDC115-OE were purchased from GenePharma (Shanghai, China). HepG-2 and HCCLM-3 cells were infected with lentivirus (MOI: HepG-2 cell = 80 pfu/cell; HCCLM-3 cell = 100 pfu/cell) with hexadimethrine bromide (5 μg/mL, GenePharma) for 72 h and puromycin (GenePharma) at the concentration of 2 μg/mL (HepG-2) or 2.5 μg/mL (HCCLM-3) was used to select for stably transfected cells.
Hepg2
HepG2 is a cell line derived from human hepatocellular carcinoma. It is a commonly used in vitro model for studies related to liver function and metabolism.
Lab products found in correlation
9 protocols using hepg2
Liver Cancer Cell Line Cultivation and Manipulation
The lentivirus vectors LV–NC–shRNA, LV-CCDC115-shRNA and LV-CCDC115-OE were purchased from GenePharma (Shanghai, China). HepG-2 and HCCLM-3 cells were infected with lentivirus (MOI: HepG-2 cell = 80 pfu/cell; HCCLM-3 cell = 100 pfu/cell) with hexadimethrine bromide (5 μg/mL, GenePharma) for 72 h and puromycin (GenePharma) at the concentration of 2 μg/mL (HepG-2) or 2.5 μg/mL (HCCLM-3) was used to select for stably transfected cells.
Silencing Oncogenic Pathways in HepG2 Cells
Small double-strand interference RNAs (siRNAs) for LASER (CCUCUUCUAAGCUCUUUAUTT), LSD1 (GAAGCTACATCTTACCTTA), EZH2 (GCTGAAGCCTCAATGTTTA), SREBP2 (CAAGGAGAGTCTATACTGT), CoREST(AAGAUUGUCCCGUUCUUGACU), LXRα (CTGCCCAGCAACAGTGTAA) and control scramble siRNA (UUCUCCGAACGUGUCACGUTT) were synthesized by GenePharma (Shanghai, China).
For RNAi assay, HepG2 cells were seeded at a density of 3.0 × 105 cells per well in a 6-well plate, when the density of cell reach to 70–90% the next day, transfection was performed. After the density of the cells reached to 70–90%, transfection was performed by incubating the siRNA with Lipofectamine RNAiMAX in Opti-MEM for 30 min at room temperature to allow siRNA-lipid complexes to form. Then, the mixed reagents were added to the target cells for a final concentration of 50 nM siRNA. After incubation with siRNA for 48 hrs, the cells were harvested for the experiments.
Transfection of Hepatoma Cell Lines
Modulation of circABCB10 and miR-670-3p in HCC
si-circABCB10, si-HMG20A, miR-670-3p mimetic, miR-670-3p agomi (GenePharma, Shanghai, China) was transfected into cells using Lipofectamine 2000 (Invitrogen, Waltham, MA, USA). The sequence of si-circABCB10 was as follows: 5′-TGGTGAAATAAATATGCGCAA-3′. The human cDNA sequence of circABCB10 was cloned into the pcD-ciR vector to construct a circABCB10 overexpression plasmid and transfected with Lipofectamine 2000 (Invitrogen).
Modulating circFASN and miR-33a in Liver Cancer
For circFASN overexpression and silencing, the circFASN plasmid and siRNA targeting the junction region of circFASN were purchased from Guangzhou Geneseed Biotech Co (Guangzhou, China). Hep-G2 and Huh7 cells were transfected with the overexpression plasmid or siRNA by using Lipo3000 Transfection Reagent (Invitrogen, USA).
For miR-33a overexpression and inhibition, Hep-G2 and Huh7 cells were transfected with 50 nM miRNA mimics (miR-33a) or 100 nM miRNA inhibitor (anti-miR-33a) (GenePharma, Shanghai, China) by using Lipo3000 Transfection Reagent (Invitrogen). Control groups were treated with equal concentrations of nontargeting mimic or inhibitor negative control sequences to control for nonspecific effects.
Silencing NPM1 in HepG2 Liver Cancer Cells
Liver Cell Line Culture and Transfection
HepG2 cells were transfected with miR-10b-5p mimics, mimics NC (GenePharma, China), oe-NC, or oe-SLC38A2 vector (HonorGene, China). SK-Hep-1 cells were transfected with miR-10b-5p inhibitors and inhibitor NC (GenePharma, China) using Lipofectamine 2000 (#11668019, Thermo Fisher, USA) according to the manufacturer’s guidelines. To induce apoptosis, SK-Hep-1 and HepG2 cells were treated with the apoptosis inducer staurosporine (STS, 5 μM, #S1421, Selleck, USA) for 12 h.
Human HCC Cell Culture Protocol
Transfection of HCC cell lines
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!